<PAGE> 1
- ------------------------------------
OMB APPROVAL
- ------------------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response.............14.90
- ------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
Millennium Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock
- --------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
59990210
- --------------------------------------------------------------------------------
(CUSIP NUMBER)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing of this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SEC 1745 (2-95)
<PAGE> 2
EXPLANATORY NOTES:
NOTE 1:
The following is a list of all reporting persons [and their respective partners]
as originally set forth on a Schedule 13G filed with the Securities and Exchange
Commission by Mayfield VII et al., on February 14, 1997, with respect to the
ownership of securities of Millennium Pharmaceuticals, Inc.:
Mayfield VII Kevin A. Fong
Mayfield VII Management Partners William D. Unger
Mayfield Medical Partners 1992 Wendell G. Van Auken, III
Mayfield Associates Fund II Michael J. Levinthal
Yogen K. Dalal A. Grant Heidrich, III
F. Gibson Myers, Jr.
NOTE 2:
This Amendment No. 1 is being filed for the sole purpose of correcting an
inadvertent omission of a general partner of Mayfield VII Management Partners in
Exhibit C.
<PAGE> 3
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
March 31, 1997
------------------------
Date
MAYFIELD VII,
A California Limited Partnership
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Authorized Signatory
MAYFIELD VII MANAGEMENT PARTNERS
A California Limited Partnership
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Authorized Signatory
MAYFIELD ASSOCIATES FUND II,
A California Limited Partnership
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Authorized Signatory
MAYFIELD MEDICAL PARTNERS 1992,
A California partnership
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Authorized Signatory
YOGEN K. DALAL
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Attorney In Fact
<PAGE> 4
F. GIBSON MYERS, JR.
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Attorney In Fact
KEVIN A. FONG
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Attorney In Fact
WILLIAM D. UNGER
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Attorney In Fact
WENDELL G. VAN AUKEN, III
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Attorney In Fact
MICHAEL J. LEVINTHAL
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Attorney In Fact
A. GRANT HEIDRICH, III
By: /s/ George A. Pavlov
--------------------------------
George A. Pavlov, Attorney In Fact
<PAGE> 5
EXHIBIT C
LIST OF GENERAL PARTNERS
The following list sets forth the General Partners with respect to certain of
the Mayfield Entities:
The General Partner of Mayfield VI Investment Partners is Mayfield VI Management
Partners. The General Partners of Mayfield VI Management Partners are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal (6) Kevin A. Fong
The General Partner of Mayfield VII is Mayfield VII Management Partners. The
General Partners of Mayfield VII Management Partners are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal (6) Kevin A. Fong
(7) Yogen K. Dalal
The General Partners of Mayfield Associates Fund are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal
The General Partners of Mayfield Associates Fund II are:
(1) F. Gibson Myers, Jr. (4) William D. Unger
(2) A. Grant Heidrich, III (5) Wendell G. Van Auken, III
(3) Michael J. Levinthal (6) Kevin A. Fong
(7) Yogen K. Dalal
The General Partner of Mayfield Medical Partners is:
(1) Mayfield VI Investment Partners (The General Partners of which have been
listed above)
The General Partner of Mayfield Medical Partners 1992 is:
(1) Mayfield VII (The General Partners of which have been listed above)
The General Partners of Mayfield Software Technology Partners are:
(1) Mayfield VI Investment Partners (The General Partners of which have been
listed above)
(2) Yogen K. Dalal
